Sri Bhava Biotech Private Limited - Company Profile

It is a construction private limited company based in Eluru, Andhra Pradesh, India, established in 2012.
2012 Eluru, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Sri Bhava Biotech Private Limited

Sri Bhava Biotech Private Limited, a struck off private limited company, was established on 08 February 2012 in Eluru, Andhra Pradesh, India. Engaging in buildings within the construction sector, it holds CIN: U01403AP2012PTC078987. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.25 M.

Its leadership includes Venkata Swamy Achanta (Director), Ravindra Rao Bandi (Director). Its latest AGM occurred on 22 September 2016, with the balance sheet filed on 31 March 2016. It is based at Hno 25-13-20,404 S R Towers Asimha Rao Pet, Eluru, Andhra Pradesh, 534006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U01403AP2012PTC078987

  • Registration Number

    078987

  • Incorporation Date

    08 February 2012

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.25 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.25 M
  • Company Age 14 Year, 4 Days
  • Last Filing with ROC 31 Mar 2016
Company report

Sri Bhava Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sri Bhava Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sri Bhava Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Swamy Achanta Director 08 Feb 2012 Current
Ravindra Rao Bandi Director 08 Feb 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Bhava Biotech.

Enhance accessibility to Sri Bhava Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sri Bhava Biotech revenue growth over time
Sri Bhava Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Bhava Biotech?

In 2016, Sri Bhava Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sri Bhava Biotech?

Unlock and access historical data on people associated with Sri Bhava Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sri Bhava Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Bhava Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Bhava Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sri Bhava Biotech Private Limited last Annual general meeting of members was held on 22 Sep 2016 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Sri Bhava Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Vijayawada. was completed.

  • Director Appointment

    The activity Venkata Swamy Achanta was appointed as a Director was appointed as a Director on 08 Feb 2012 & has been associated with this company since 14 years 4 days . was completed.

  • Director Appointment

    The activity Ravindra Rao Bandi was appointed as a Director was appointed as a Director on 08 Feb 2012 & has been associated with this company since 14 years 4 days . was completed.

  • Company Incorporation

    The activity Sri Bhava Biotech Private Limited was registered on 08 Feb 2012 with Roc Vijayawada & aged 14 years 4 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sri Bhava Biotech Private Limited?

The CIN of Sri Bhava Biotech Private Limited is U01403AP2012PTC078987.

Where is Sri Bhava Biotech Private Limited headquartered?

Sri Bhava Biotech Private Limited is headquartered at Hno 25-13-20,404 S R Towers Asimha Rao Pet, Eluru, Andhra Pradesh, 534006.

When was Sri Bhava Biotech Private Limited incorporated?

Sri Bhava Biotech Private Limited was incorporated on 08 February 2012.

Who are the current directors of Sri Bhava Biotech Private Limited?

The current directors of Sri Bhava Biotech Private Limited are

What is the primary industry of Sri Bhava Biotech Private Limited?

The primary industry of Sri Bhava Biotech Private Limited is Construction.

Is Sri Bhava Biotech Private Limited a listed company?

Sri Bhava Biotech Private Limited is unlisted.

What is the capital structure of Sri Bhava Biotech Private Limited?

The authorized capital of Sri Bhava Biotech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.25 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available